NFKB1 and hepatocellular carcinoma: Studies have shown that MIR503HG inhibits HCC cell invasion and migration via suppressing the NF-κB signaling pathway [21], suggesting the involvement of the NF-κB signaling pathway in MIR-503HG-mediated HCC cell invasion and migration.